286 related articles for article (PubMed ID: 24728654)
1. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.
Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Cancer: A Review.
Park W; Chawla A; O'Reilly EM
JAMA; 2021 Sep; 326(9):851-862. PubMed ID: 34547082
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
Silvestris N; Longo V; Cellini F; Reni M; Bittoni A; Cataldo I; Partelli S; Falconi M; Scarpa A; Brunetti O; Lorusso V; Santini D; Morganti A; Valentini V; Cascinu S
Crit Rev Oncol Hematol; 2016 Feb; 98():309-24. PubMed ID: 26653573
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.
Chiaravalli M; Reni M; O'Reilly EM
Cancer Treat Rev; 2017 Nov; 60():32-43. PubMed ID: 28869888
[TBL] [Abstract][Full Text] [Related]
6. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo M; Álvarez R; Gallego J; Guillén-Ponce C; Laquente B; Macarulla T; Muñoz A; Salgado M; Vera R; Adeva J; Alés I; Arévalo S; Blázquez J; Calsina A; Carmona A; de Madaria E; Díaz R; Díez L; Fernández T; de Paredes BG; Gallardo ME; González I; Hernando O; Jiménez P; López A; López C; López-Ríos F; Martín E; Martínez J; Martínez A; Montans J; Pazo R; Plaza JC; Peiró I; Reina JJ; Sanjuanbenito A; Yaya R; Carrato A
Clin Transl Oncol; 2017 Jun; 19(6):667-681. PubMed ID: 27995549
[TBL] [Abstract][Full Text] [Related]
7. Evolving pancreatic cancer treatment: From diagnosis to healthcare management.
Milella M; Bassi C; Boggi U; Brunetti O; Cavaliere A; Crippa S; De Vita F; Falconi M; Frassineti GL; Giommoni E; Macchini M; Malleo G; Silvestris N; Tudisco A; Vasile E; Reni M
Crit Rev Oncol Hematol; 2022 Jan; 169():103571. PubMed ID: 34923121
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic adenocarcinoma: therapeutical update].
Khosravi Shahi P; Díaz Muñoz de la Espada VM
An Med Interna; 2005 Aug; 22(8):390-4. PubMed ID: 16351494
[TBL] [Abstract][Full Text] [Related]
9. Ductal pancreatic adenocarcinoma.
Seufferlein T; Porzner M; Heinemann V; Tannapfel A; Stuschke M; Uhl W
Dtsch Arztebl Int; 2014 May; 111(22):396-402. PubMed ID: 24980565
[TBL] [Abstract][Full Text] [Related]
10. Cystic neoplasms of the exocrine pancreas.
Campbell F; Azadeh B
Histopathology; 2008 Apr; 52(5):539-51. PubMed ID: 17903202
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Sohal DP; Mangu PB; Khorana AA; Shah MA; Philip PA; O'Reilly EM; Uronis HE; Ramanathan RK; Crane CH; Engebretson A; Ruggiero JT; Copur MS; Lau M; Urba S; Laheru D
J Clin Oncol; 2016 Aug; 34(23):2784-96. PubMed ID: 27247222
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: An update on diagnosis and management.
Loveday BPT; Lipton L; Thomson BN
Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
[TBL] [Abstract][Full Text] [Related]
13. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence.
Müller PC; Frey MC; Ruzza CM; Nickel F; Jost C; Gwerder C; Hackert T; Z'graggen K; Kessler U
Pharmacology; 2021; 106(3-4):143-153. PubMed ID: 32966993
[TBL] [Abstract][Full Text] [Related]
15. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
[TBL] [Abstract][Full Text] [Related]
16. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).
Vera R; Dotor E; Feliu J; González E; Laquente B; Macarulla T; Martínez E; Maurel J; Salgado M; Manzano JL
Clin Transl Oncol; 2016 Dec; 18(12):1172-1178. PubMed ID: 27896637
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma.
Tesfaye AA; Philip PA
Clin Adv Hematol Oncol; 2019 Jan; 17(1):54-63. PubMed ID: 30843899
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and neoadjuvant treatment in pancreatic cancer.
Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
World J Gastroenterol; 2012 Apr; 18(14):1565-72. PubMed ID: 22529684
[TBL] [Abstract][Full Text] [Related]
20. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma.
Hegewisch-Becker S; Aldaoud A; Wolf T; Krammer-Steiner B; Linde H; Scheiner-Sparna R; Hamm D; Jänicke M; Marschner N;
Int J Cancer; 2019 Mar; 144(5):981-990. PubMed ID: 30006989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
